9 consecutive years of industry-leading performance No.1 exporter of health functional food in Korea

Atomy HemoHIM recorded its largest annual sales of KRW 185.1 billion in the past year.
HemoHIM crossed the KRW 100 billion threshold in domestic annual sales in 2014 with KRW 106.7 billion. Since then, the company has recorded annual sales of more than KRW 100 billion for nine consecutive years, and is on the verge of reaching the KRW 200 billion mark. Global cumulative sales exceeded KRW 2 trillion in 2022.

According to the domestic network marketing company information released by the Fair Trade Commission on July 26, Atomy HemoHIM has been the No.1 best-selling product in the network marketing industry for 9 consecutive years, from 2014 to 2022.
Atomy HemoHIM is Korea’s first individually recognized health functional food developed with the patented main ingredients “HemoHIM Angelica Gigas Extract Mixture”, developed by the Korea Atomic Energy Research Institute. According to the “2021 Production Performance of Food, etc.” released by the Ministry of Food and Drug Safety in 2022, the “HemoHIM Angelica Gigas Extract Mixture” exported $60.48 million (about KRW 70 billion based on the average exchange rate in 2021), surpassing red ginseng, which exported $48.32 million (about KRW 55.3 billion), making it the highest export value among domestic health functional foods.